ГІПЕРОКСАЛУРІЯ: МЕХАНІЗМИ ФОРМУВАННЯ ТА НАСЛІДКИ
Анотація
Робота є оглядом літератури, в якій висвітлюються сучасні погляди на механізми, що лежать в основі формування гіпероксалурії та можливі клінічні наслідки. Детально викладено хімічні властивості оксалату, його екзо- й ендогенні ресурси в організмі людини, механізми абсорбції оксалату у шлунково-кишковому тракті та ниркової екскреції. У заключному розділі основна увага приділяється існуючим та перспективним підходам до лікування гіпероксалурії.
Завантаження
Посилання
Колесник М. Гіпероксалурія та показники мукозального імунітету хворих на хронічну хворобу нирок І-ІІ ст.: пієлонефрит / М. Колесник, Н. Сташевська, Н. Степанова, В. Дріянська, та інші // Український Журнал Нефрології та Діалізу. - 2014. -№3 (43). - С. 42-48.
Колесник М. Гіпероксалурія у хворих на пієлонефрит: потенційна роль у прогресуванні хронічної хвороби нирок / М. Колесник, Н. Степанова, Н. Сташевська, Л. Суржко // Український журнал нефрології та діалізу. – 2012. -№2(34).-С. 28-33.
Aaron W. Miller. The Metabolic and Ecological Interactions of Oxalate-Degrading Bacteria in the Mammalian Gut. / Aaron W. Miller, Denise Dearing // Pathogens – 2013. –V. 2. – P. 636-652.
Abeysekera R. A. Star fruit toxicity: a cause of both acute kidney injury and chronic kidney disease: a report of two cases (Electronic resource) / Abeysekera R. A., Wijetunge S., Nanayakkara N., [et al.] // BMC Research Notes. – 2015. – V. 8. – Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683968/
Agrawal V. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass / AgrawalV., LiuX. J., CampfieldT., [etal.] // Surg Obes Relat Dis. - 2013.-V. 10. - P. 88-94.
Albersmeyer M. Acute kidney injury after ingestion of rhubarb: secondary oxalate nephropathy in a patient with type 1 diabetes (Electronic resource) / Albersmeyer M., Hilge R., Schrttle A., Weiss
M., Sitter T., Vielhauer V. // BMC Nephrology. – 2012. –V. 13. – Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504561
Al-Wahsh I. Acute probiotic ingestion reduces gastrointestinal oxalate absorption in healthy subjects / Al-Wahsh I., Wu Y., Liebman M. // Urol. Res. - 2012. - V. 40 (3). - P. 191-196.
An institutional experience of pre-emptive liver transplantation for pediatric primary hyperoxaluria type 1 / Khorsandi S. E., Samyn M., Hassan A., Vilca-Melendez H., [et al.] // Pediatr Transplant. 2016. – V. 20(4).-P. 523-529.
Antonelli J. A. Defining variation in urinary oxalate in hyperoxaluric stone-formers / Antonelli J. A., Langman С. B., Odom C., Poindexter J., [et al.] // J Endourol. - 2013. - V. 27 (12). - P. 1530-1534.
Bakul G. Acute oxalate nephropathy due to ‘Averrhoa bilimbi’ fruit juice ingestion / Bakul G., Unni V. N., Seethaleksmy N. V., Mathew A., Rajesh R., [et al.] // Indian J Nephrol. – 2013. – V. 23. - P. 297-300.
Barnett C. The presence of Oxalobacter formigenes in the microbiome of healthy young adults Barnett C., Nazzal L., Goldfarb D. S., Blaser M. J. // The Journal of urology. - 2016. - V. 195 (2). - P. 499-506.
Barr-Beare E. The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits (Electronic resource) / Barr-Beare E., Saxena V., Hilt E. E., [et al.] // Sands JM, ed. PLoS ONE. - 2015. – V. 10 (10). – Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598009
Bhasin B. Primary and secondary hyperoxaluria: Understanding the enigma / Bhasin B., Urekli H. M., Atta M. G. //World Journal of Nephrology. – 2015. –V. – 4 (2). - P. 235-244.
Canales В. K. Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate / Canales В. K., Ellen J., Khan S. R., [et al.] // J Urol. - 2013. - V. 190. - P. 1102-1109.
Cartery C. Oxalate Nephropathy Associated with Chronic Pancreatitis / Cartery C., Faguer S., Karras A., [et al.] II Clinical Journal of the American Society of Nephrology: CJASN. – 2011. – V. 6 (8). – P. 1895-1902.
Chen P. Correlation between urinary stones and urinary tract infections / Chen P., Zhang L., Meng B. // Zhonghua Liu Xing Bing Xue Za Zhi. – 2014. -V.35(5).-P. 597-599.
Cochat Р. Primary hyperoxaluria / Cochat P., Rumsby G. // N Engl J Med. - 2013. - V. 369. - P. 649-658.
Cohen-Bucay A. Acute oxalate nephropathy associated with Clostridium difficile colitis / Cohen- Bucay A., Garimella P., Ezeokonkwo C., Bijol V., Strom J. A., Jaber B. L. // Am J Kidney Dis. - 2014. – V. 63(1).-P. 113-118.
Combined kidney and intestinal transplantation in patients with enteric hyperoxaluria secondary to short bowel syndrome / Ceulemans L. J., Nijs Y., Nuytens F., De Hertogh G., Claes K., [et al.]. // Am J Transplant.-2013.-V. 13.-P. 1910-1914.
Cossey L. N. Oxalate nephropathy and intravenous vitamin C / Cossey L. N., Rahim F., Larsen С. P. // Am J Kidney Dis. - 2013. -V. 61. - P. 1032-1035.
Di Cerbo A. Mechanisms and therapeutic effectiveness of lactobacilli / Di Cerbo A., Palmieri B., Aponte M., [et al.] // Journal of Clinical Pathology - 2016. -V. 69 (3). - P. 187-203.
Dutta C. Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1 / Dutta C., Avitahl-Curtis N., Pursell N., [et al.] // Molecular Therapy. – 2016. – V. 24 (4).-P. 770-778.
Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn’s disease / Hueppelshaeuser R., von Unruh G. E., Habbig S., Beck В. B., [et al.] // Pediatr Nephrol. – 2012. – V. 27(7).-P. 1103-1109.
ERRATUM: Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group / Prezioso D., Strazzullo P., Lotti T., Bianchi G., Borghi L., Caione P., Carini M., [et al.] // Arch Ital Urol Androl. – 2016. – V. 31, 88(l).-76p.
Ferraro P. M. Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones / Ferraro P. M., Curhan G. C., Gambaro G., Taylor E. N. // Kidney Dis. - 2016. - V. 67 (3). - P. 400-407.
Freel R. W. Transcellular oxalate and Cl- absorption in mouse intestine is mediated by the DRA anion exchanger Slc26a3, and DRA deletion decreases urinary oxalate / Freel R. W., Whittamore J. M., Hatch M. // American Journal of Physiology - Gastrointestinal and Liver Physiology. – 2013. – V. 305 (7). - P. 520-527.
Gonzalez R. D. Kidney Stone Risk Following Modern Bariatric Surgery / Gonzalez R. D., Canales В. K. // Current urology reports. – 2014. -V. 15(5).-P. 401.
Grases F. New aspects on the composition, structure and origin of calcium oxalate monohydrate calculi / Grases F., March J. G., Conte A., Costa- Bauza A. // Eur Urol. - 1993. - V. - 24 (3). - P. 381-386.
Guidelines on Urolithiasis / C. T rk, T. Knoll, A. Petrik [et al.] // European Association of Urology. – 2013.
Gurm H. Vitamin C-induced oxalate nephropathy: a case report / Gurm H., Sheta M. A., Nivera N., Tunkel A. // J Community Hosp Intern Med Perspect. - 2012. – V. 2. - P. 17718.
Harambat J. Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy / Harambat J., van Stralen K. J., Espinosa L., Groothoff J. W., Hulton S. A., [et al.] // European Society for Pediatric Nephrology/ European Renal Association-European Dialysis and Transplant Association (ESPN/ERA-EDTA) Registry Clin J Am Soc Nephrol. – 2012. – V. 7 (3).-P. 458-465.
Hassan I. Chronic renal failure secondary to oxalate nephropathy: a preventable complication after jejunoileal bypass / Hassan I. , Juncos L. A., Milliner D. S., Sarmiento J. M., [et al.] // Clin Proc. - 2001. - V. 76. - P. 758-760.
Hatch M. Intestinal transport of an obdurate anion: oxalate / Hatch M., Freel R. W. // Urol. Res. – 2005. – V. 33(1).-P. 1-16.
Hatch M. The Roles and Mechanisms of Intestinal Oxalate Transport in Oxalate Homeostasis / Hatch M., Freel R. W. // Seminars in nephrology. – 2008. -V.28(2).-P. 143-151.
HerlitzL. C. Crystalline nephropathies / Herlitz L. C. , D’AgatiV. D., Markowitz G. S.// Arch Pathol Lab Med. – 2012. – V. 136.-P. 713-720.
Holmes R. P. Contribution of dietary oxalate to urinary oxalate excretion / Holmes R. P., Goodman H. O., Assimos D. G. // Kidney Int. – 2001. – V.59(l).-P. 270-276.
Holmes R. P. Impact of dietary oxalate on kidney stone formation / Holmes R. P., Assimos D. G.// Urol Res. - 2004. - V. 32 (5). - P. 311-316.
Holmes R. P. The Hatch M. A Human Strain of Oxalobacter (HC-1) Promotes Enteric Oxalate Secretion in the Small Intestine of Mice and Reduces Urinary Oxalate Excretion (Electronic resource) / Hatch M., Freel R. W. // Urolithiasis. – 2013. – V. 41 (5). – Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815490/
Hoppe B. An update on primary hyperoxaluria / Hoppe B. // Nat Rev Nephrol. – 2012. – V. 8. – P. 467-475.
Hoyer-Kuhn H. Vitamin B6 in Primary Hyperoxaluria I: First Prospective Trial after 40 Years of Practice. Clin J Am Soc Nephrol / Heike Hoyer-Kuhn, Sina Kohbrok, RuthVolland, [et al.] // 2014. –V.7,9 (3). - P. 468-477.
Humayun Y. Acute oxalate nephropathy associated with orlistat / Humayun Y., Ball K. C., Lewin J. R., Lerant A. A., Fulop T. // Journal of Nephropathology. – 2016. –V.5 (2). – P. 79-83.
Hyperoxaluria: a gut-kidney axis? / Robijn S., Hoppe B., Vervaet B. A., D’Haese P. C., Verhulst A. //Kidney Int. - 2011. -V. - 80. P. 1146-1158.
lilies F. Clearance and removal of oxalate in children on intensified dia//lysis for primary hyperoxaluria type / lilies F., Bonzel К. E., Wingen A. M. , Latta К., Hoyer P. F.// Kidney Int. – 2006. – V. 70. - P. 1642-1648.
Jakobsson H. E. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome (Electronic resource) / Jakobsson H. E., Jernberg C., Andersson A. F., Sj lund-Karlsson M., [et al.] // PLoS One. 2010. — Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844414
Jandhyala S. M. Role of the normal gut microbiota / Jandhyala S. M., Talukdar R., Subramanyam C., Vuyyuru H., [et al] // World Journal of Gastroenterology: WJG. - 2015. - V. 21 (29). - P. 8787-8803.
Jernberg C. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota / Jernberg C., Lofmark S., Edlund C., Jansson J. К. //ISME J. - 2007. - V. 1. - P. 56-66.
Jiang J. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion / J. Jiang, J. Knight, L. H. Easter, R. Neiberg [et al.] // J Urol. - 2011. - Vol. 186 (l).-P. 135-139.
Kaufman David W. Oxalobacter formigenes May Reduce the Risk of Calcium Oxalate Kidney Stones / David W. Kaufman, Judith P. Kelly, Gary C. Curhan, Theresa E. Anderson [et al.] // J Am Soc Nephrol.-2008.-Vol. 19 (6). - P. 1197-1203.
Khan S. R. Crystal-induced inflammation of the kidneys: Results from human studies, animal models, and tissue-culture studies / Khan S. R. // Clin Exp Nephrol. - 2004. -№8,- P. 75-88.
Knauf F. Net Intestinal Transport of Oxalate Reflects Passive Absorption and SLC26A6- mediated Secretion / Knauf F., Ко N., Jiang Z., [et al] II Journal of the American Society of Nephrology. - 2011. – V. 22 (12). - P. 2247-2255.
Knight J. Ascorbic acid intake and oxalate synthesis (Electronic resource) / Knight J., Madduma- Liyanage K., Mobley J. A., [et al.] // Urolithiasis. – 2016. – Mode of access: http://www.ncbi.nlm.nih.gov/pubmed/27002809
Knight J. Hydroxyproline ingestion and urinary oxalate and glycolate excretion / Knight J., JiangJ ., Assimos D., Holmes R. // Kidney international. – 2006. – V. 70 (11). – P. 1929-1934.
Kolesnyk M. Effect of hyperoxaluria on the progression of chronic kidney disease in women with recurrent uncomplicated pyelonephritis / M. Kolesnyk, N. Stepanova, L. Surzhko, N. Stashevska //
Nephrology Dialysis Transplantation. – 2012. – Vol. 27 (Suppl 2). - P. 107.
Kolesnyk M. Hyperoxaluria associated with recurrent pyelonephritis in women (Electronic resource) / Kolesnyk M., Stepanova N., Stashevska N. // World Congress ofNephrology. – 2013. – Mode of access: http://www.abstracts2view.com/wcn/view.php?nu=WCN13L_1615
Kolesnyk M. Hyperoxaluria mediated renal injury in women with recurrent pyelonephritis / Kolesnyk M., Stepanova N., Driyanska V., Stashevska N., Kundin V. //Nephrology Dialysis Transplantation. -2013.-V. 26 (Suppl.). – P. 114.
Krick W. Ability of sat-1 to transport sulfate, bicarbonate, or oxalate under physiological conditions / Krick W., Schnedler N., Burckhardt G. [et al.] // Am J Physiol Renal Physiol. – 2009. – V. 297. – P.145-154.
Kumar R. Fat malabsorption and increased intestinal oxalate absorption are common after Roux- en-Y gastric bypass surgery / Kumar R., Lieske J. C., Collazo-Clavell M. L., [et al.] // Surgery. – 2011. – V. 149. - P. 654-661.
Kynast-Gales S. A. Food oxalate: an international database / Kynast-Gales S. A., Massey L. K. // J Am Diet Assoc. – 2007. –V. 107. – P. 1099.
Famarche J. Vitamin C-induced oxalate nephropathy (Electronic resource) / Lamarche J., Nair R., Peguero A., Courville C. // Int J Nephrol. – 2011. – Mode of access: http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3096888/
Lange J. N. Sensitivity of Human Strains of Oxalobacter formigenes to Commonly Prescribed Antibiotics / Lange J. N., Wood K. D., Wong H., [et al.] Ц Urology. - 2012. - V. 79 (6). - P. 1286-1289.
Leal C. Herlitz. Crystalline Nephropathies / Leal C. Herlitz, Vivette D. D’Agati, Glen S. Markowitz // Archives of Pathology & Laboratory Medicine. – 2012. – V. - 136 (7). - P. 713-720.
Liebman M. Probiotics and Other Key Determinants of Dietary Oxalate Absorption / Michael Liebman, Ismail A. Al-Wahsh // Adv. Nutr. – 2011. – V. 2 (3). - P. 254-260.
Lieske J. C. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation / Lieske J. C., Tremaine W. J., De Simone C., O’Connor H. M., [et al.] //Kidney Int. – 2010. – V. 78. – P. 1178-1185.
Massey L. К Food oxalate: factors affecting measurement, biologicalvariation, andbioavailability / Massey L. K. // J Am Diet Assoc. – 2007. – V. – 107(7). – P. 1191-1194.
Mogna L. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? / Mogna L., Pane M., Nicola S., Raiteri E. // J Clin Gastroenterol. – 2014. – V. 48, Suppl 1. - P. 91-95.
Monico C. G. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic, calcium oxalate urolithiasis / Monico C. G., Rossetti S., Belostotsky R., [et al.] // Clin J Am Soc Nephrol. - 2011. - V. 6. - P. 2289-2295.
Nazzal L. Enteric hyperoxaluria: an important cause of end-stage kidney disease / Nazzal L., Puri S., Goldfarb D. // Nephrol. Dial. Transplant. – 2016. – V. 31 (3).-P. 375-382.
Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease / Glew R. H., Sun Y., Horowitz B. L., et al. // World Journal of Nephrology. –2014. –V. 3 (4). – P. 122-142.
Panda S. Short-term effect of antibiotics on human gut microbiota (Electronic resource) / Panda S., Elkhader I., Casellas F., Lopez Vivancos J., [et al.] // PLoS One. - 2014. - V. 9 (4). - Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991704
Peanut-induced acute oxalate nephropathy with acute kidney injury / Park H., Eom M., Won Yang J., Geun Han B., [et al.] //Kidney Research and Clinical Practice. - 2014. - V. 33 (2). - P. 109
Ritz E. Bariatric surgery and the kidney-much benefit, but also potential harm / Ritz E. // Clinical Kidney Journal. - 2013.-V. 6 (4). - P. 368-372.
Salido E. Primary hyperoxalurias: disorders of glyoxylate detoxification / Salido E., Pey A. L., Rodriguez R., Lorenzo V. // Biochim Biophys Acta. - 2012. - V. 1822 (9). - P. 1453-1464.
Sasikumar P. Secretion of Biologically Active Heterologous Oxalate Decarboxylase (OxdC) in Lactobacillus plantarum WCFS1 Using Homologous Signal Peptides (Electronic resource) / Sasikumar P., Gomathi S., Anbazhagan K., Selvam G. S. //BioMed Research International. – 2013. – Mode of access: http://www.ncbi.nlm.nih. gov/pmc/articles/PMC3732618/doi:10.1155/201
Siener R. Determinants of urolithiasis in patients with intestinal fat malabsorption / Siener R., Petzold J., Bitterlich N., Alteheld B., Metzner C. // Urology. - 2013. – V. 81. – P. 17-24.
Siener R. Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria / Siener R., Bade D.J., Hesse A., Hoppe B.// J Transl Med. – 2013. – V. ll.-P. 306.
Sorensen M. D. Impact of Nutritional Factors on Incident Kidney Stone Formation: A Report From the WHI OS / Sorensen M. D., Kahn A. J., Reiner A. P., et al. II The Journal of urology. – 2012. – V. 187(5).-P. 1645-1649.
Stackhouse G. B. Calcium Physiology. / Stackhouse G. B., Stoller M. L. IIUrinary Stone Disease. – 2007. – Humana Press Inc. – P. 85–101.
Stepanova N. Hyperoxaluria in women with recurrent pyelonephritis associated with the deficit of Lactobacillus spp. in the gut and vaginal microbiota / Stepanova N., Kolesnyk M., Stashevska N. // European urology supplements. – 2015. – P. 50-51.
Stieger B. Regulation of the expression of the hepatocellular sulfate-oxalate exchanger SAT-1 (SLC26A1) by glyoxylate: a metabolic link between liver and kidney? / Stieger B. // J Hepatol. – 2011. -V. 54. – P. 406-407.
Susan R. Marengo. Oxalate in Renal Stone Disease: The Terminal Metabolite: Excretion of Oxalate. / Susan R. Marengo, Andrea M. P. //Nat Clin Pract Nephrol. - 2008. –V.4 (7). -P.- 368-377.
Tang X. Acute and chronic kidney injury in nephrolithiasis / Xiaojing Tang, John C. Lieske // Curr Opin Nephrol Hypertens. – 2014. – V. 23 (4). – P. 385-390.
Taylor E. N. DASH-Style Diet Associates with Reduced Risk for Kidney Stones / Taylor E. N., Fung T. T., Curhan G. C. // Journal of the American Society of Nephrology. – 2009. – V. 20 (10). – P. 2253-2259.
Tran M. H. Kidney transplantation in obese patients / Tran M. H., Foster C. E., Kalantar-Zadeh K., Ichii H. // World Journal of Transplantation. – 2016.-V.6(1).-P. 135-143.
Turroni S. Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: Impact of acidic conditions on the transcriptional levels of the oxa- lyl-CoA decarboxylase and formyl-CoA transferase genes / Turroni, S., Bendazzoli C., Dipalo S. C. F., Candela M., [et al.] // Appl. Environ. Microbiol. – 2010. – V. 76. – P. 5609-5620.
Weight loss at a high cost: Orlistat-induced late-on- set severe kidney disease / Buysschaert B., Aydin S., Morelle J., Hermans M. P., [et al.] // N. Diabetes Metab. - 2016. – V. 42 (1). - P. 62-64.
Whitson J. M. Hyperoxaluria after modern bariatric surgery: case series and literature review //Whitson J. M., Stackhouse G. B., Stoller M. L. // Int Urol Nephrol. - 2010. - V. 42. - P. 369-374.
Журнал розповсюджується за ліцензією 